Despite huge gains made in combating diseases across the continent, Africa still leads in infectious diseases. Anti-infectives, analgesics, multivitamins and hematinics account for over 60% of the market value. EB is focused on the African market. We create products that will advance our vision of Healthy Africa.

Over the past several years, there is a growing shift of disease burden from communicable to non-communicable diseases. Urbanization and lifestyle choices play a significant role here. We are increasing our basket of cardio-metabolic products, anti-depressants, oncology and respiratory medications. We want to be your one-stop shop for high quality medications in Africa, here today and ready for tomorrow.